Assessing drug exposure in rodent toxicity studies without satellite animals |
| |
Authors: | Jerry R. Nedelman Ekaterina Gibiansky Francis L. S. Tse Christine Babiuk |
| |
Affiliation: | (1) Sandoz Research Institute, 07936 East Hanover, New Jersey |
| |
Abstract: | Five major objectives for pharmacokinetic investigations in support of toxicity studies are identified as follows: Assess whether animals exhibited measurable blood concentrations in a dose-dependent manner; estimate average area under the concentration- time curve (AUC)and maximal concentration (Cmax)for each treatment group; elucidate general patterns in the concentration-time (CxT)profile, and summarize relationships between CxTand treatment group; determine CxTdependence on day into study; and judge interanimal variability and identify any animals with unusual concentration response. Such objectives are generally addressed in rodent toxicity studies by including satellite animals in the study. Satellite animals are extra animals dosed as per protocol but not subjected to toxicological and pathological observations and tests. Instead, they are used exclusively for the evaluation of pharmacokinetic characteristics of the test compound. In this paper, methods are described for achieving the five listed pharmacokinetic objectives in rodent toxicity studies without the use of satellite animals. A rat toxicity study is presented as an example. |
| |
Keywords: | toxicology pharmacokinetics AUC CxT |
本文献已被 SpringerLink 等数据库收录! |